Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 9/20 | 0.61 |
| ▸ | WDR77 | Q9BQA1 | 9/20 | 0.61 |
| ▸ | PARP1 | P09874 | 8/20 | 0.45 |
| ▸ | TNKS | O95271 | 3/20 | 0.40 |
| ▸ | TNKS2 | Q9H2K2 | 3/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31540443 | 0.89 | PRMT5 (0.57) | PRMT5WDR77PARP1TNKSTNKS2 | |
| SCHEMBL31519288 | 0.81 | PRMT5 (0.64) | PRMT5WDR77PARP1 | |
| SCHEMBL23087948 | 0.80 | PRMT5 (0.66) | PRMT5WDR77PARP1 | |
| SCHEMBL31519320 | 0.79 | PRMT5 (0.63) | PRMT5WDR77PARP1 | |
| SCHEMBL31568857 | 0.79 | PRMT5 (0.63) | PRMT5WDR77PARP1 | |
| SCHEMBL31375998 | 0.79 | PRMT5 (0.63) | PRMT5WDR77PARP1 | |
| SCHEMBL23087489 | 0.76 | PRMT5 (1.00) | PRMT5WDR77PARP1 | |
| SCHEMBL31540433 | 0.74 | PRMT5 (0.44) | PRMT5WDR77PARP1TNKSTNKS2 | |
| SCHEMBL31380379 | 0.74 | PRMT5 (0.44) | PRMT5WDR77PARP1TNKSTNKS2 | |
| SCHEMBL31540431 | 0.72 | POLB (0.46) | PRMT5WDR77PARP1TNKSTNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068985-A1 | 1-(1-OXO-1,2-DIHYDROPHTHALAZIN-6-YL)CYCLOALKYL-1-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 | BEIGENE SWITZERLAND GMBH (CH) | 2025-04-03 | — | — | WO | disclosed |
| CN-119707931-A | Intermediate and synthesis method of 1- (1-oxo-1, 2-dihydro-phthalazin-6-yl) cycloalkyl-1-carboxamide derivatives as MTA synergistic inhibitors of PRMT5 | 百济神州(北京)生物科技有限公司 | 2025-03-28 | — | — | CN | disclosed |